The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of ...

After years of ongoing shortages due to their growing popularity, all doses of both Ozempic and Wegovy are now listed as ...

It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...

All doses of the two drugs are now listed as available in the U.S., per an FDA database, although the company cautioned ...

Wegovy reduced arthritic knee pain in study subjects with high BMI. Unknown: the exact mechanism or whether it would prevent knee replacement surgery.

Ozempic, Wegovy or Mounjaro: the battle of the weight-loss injections - As weight-loss injections emerge as key players in ...

The post To Get Through the Election, Use Ozempic appeared first on Reason.com.

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...

Telehealth companies selling low-cost, compounded versions of popular weight-loss drugs, including Ozempic and Wegovy, are drawing increased interest from employers, Bloomberg reported Oct. 29.

Semaglutide, the main ingredient in Ozempic and Wegovy, improves type 2 diabetes, heart disease, smoking, and alcohol ...